aberrations in cancer cells and targeted therapies

25
Aberrations in Cancer Cells and Targeted Therapies Shermaine Mitchell July 27 2011 PhD Candidate

Upload: kirk

Post on 24-Feb-2016

54 views

Category:

Documents


0 download

DESCRIPTION

Aberrations in Cancer Cells and Targeted Therapies. Shermaine Mitchell July 27 2011 PhD Candidate. Targeted therapy. Standard Chemo-therapy. Patient. Normal cells vs. Cancer cells. Cancer…what is it?. Uncontrolled growth of abnormal cells in the body Benign and or pre-malignant tumors - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Aberrations in Cancer Cells and Targeted Therapies

Aberrations in Cancer Cells and Targeted TherapiesShermaine MitchellJuly 27 2011PhD Candidate

Page 2: Aberrations in Cancer Cells and Targeted Therapies

Targeted therapy

Standard Chemo-therapy

Patient

Page 3: Aberrations in Cancer Cells and Targeted Therapies

Normal cells vs. Cancer cells

Page 4: Aberrations in Cancer Cells and Targeted Therapies

Cancer…what is it?

Uncontrolled growth of abnormal cells in the body

Benign and or pre-malignant tumors ARE NOT CANCER A disease of the genome: Cancer is a

genetic disease1. Gain of function mutation2. Loss of function mutations3. Gene amplification4. Overexpression

Page 6: Aberrations in Cancer Cells and Targeted Therapies

Intracellular signaling

Page 8: Aberrations in Cancer Cells and Targeted Therapies

Targeted Therapy

Page 9: Aberrations in Cancer Cells and Targeted Therapies
Page 10: Aberrations in Cancer Cells and Targeted Therapies

Growth factor signaling

Page 11: Aberrations in Cancer Cells and Targeted Therapies

Overexpression of receptor

Page 12: Aberrations in Cancer Cells and Targeted Therapies

Herceptin

Page 13: Aberrations in Cancer Cells and Targeted Therapies

Mutations in Effector Molecules

Page 14: Aberrations in Cancer Cells and Targeted Therapies

Lipidmodification for function

Page 15: Aberrations in Cancer Cells and Targeted Therapies
Page 16: Aberrations in Cancer Cells and Targeted Therapies

Loss of function mutation: evading apoptosis

Page 17: Aberrations in Cancer Cells and Targeted Therapies
Page 18: Aberrations in Cancer Cells and Targeted Therapies

Onyx -015

Page 19: Aberrations in Cancer Cells and Targeted Therapies

Old Dog with New Tricks

Page 20: Aberrations in Cancer Cells and Targeted Therapies

Ovarian Cancer

Most lethal gynecological cancer

65% of patients are diagnosed with stage III or stage IV disease

Recurring and resistant to treatment

21,880 new cases 13,850 deaths 85-90% of ovarian

cancers overexpress FRα20

Nor

mal

Stag

e I

Stag

e II

Stag

e III

Stag

e IV

0.00001

0.0001

0.001

0.01

0.1

1

Rel

ativ

e FR

alp

ha T

rans

crip

ts

Courtesy of Christina Cherian

Ovarian Cancer

Page 21: Aberrations in Cancer Cells and Targeted Therapies

Mechanisms of Intracellular Folate Transport

21

• Predominant transporter of (anti)folates

Zhao R, Matherly LH, Goldman ID: Expert Rev. Mol. Med., 2009

PCFT=Proton-coupled folate transporterRFC=Reduced folate carrier

Page 22: Aberrations in Cancer Cells and Targeted Therapies

Folates Essential water soluble B

vitamin Amino acid synthesis Essential for DNA

synthesisa. Thymidylate (dTMP):TSb. Purine nucleotides : GARFT + AICARFT

Antifolates Structural analogs of folic

acid Disrupt DNA synthesis Recognized by cellular

machinery used by folates

a. receptors b. intracellular targets Inhibition of folate

dependent enzymes Nucleotide depletion

22

GARFT=Glycinamine Ribonucleotide formyl transferaseAICARFT= 5-Aminoimidozole 4-carboxamide ribonucleotide formyl transferaseTS= Thymidylate Synthase

Page 23: Aberrations in Cancer Cells and Targeted Therapies

Normal vs. Cancer cellsBlood Lumen

BloodLumen Normal Solid Tumors

RFC

vv

PCFT FRα23

Page 24: Aberrations in Cancer Cells and Targeted Therapies

Antifolates

Aminopterin MTX Pemetrexed…

Page 25: Aberrations in Cancer Cells and Targeted Therapies

Questions????